1. |
Eren E, Ellidag HY, Cekin Y, et al. Heart valve disease: the role of calcidiol deficiency, elevated parathyroid hormone levels and oxidative stress in mitral and aortic valve insufficiency. Redox Rep, 2014, 19(1): 34-39.
|
2. |
Talluto CJ, Silverman NH. Aortic and mitral valve stenosis with regurgitation: not due to rheumatic heart disease. Echocar-
diography, 2011, 28(2): E24-E27.
|
3. |
Venardos N, Nadlonek NA, Zhan Q, et al. Aortic valve calcification is mediated by a differential response of aortic valve interstitial cells to inflammation. J Surg Res, 2014, 190(1): 1-8.
|
4. |
Chung MT, Cheng PY, Lam KK, et al. Cardioprotective effects of long-term treatment with raloxifene, a selective estrogen receptor modulator, on myocardial ischemia/reperfusion injury in ovariectomized rats. Menopause, 2010, 17(1): 127-134.
|
5. |
Stamatelopoulos KS, Lekakis JP, Poulakaki NA, et al. Tamoxifen improves endothelial function and reduces carotid intima-media thickness in postmenopausal women. Am Heart J, 2004, 147(6): 1093-1099.
|
6. |
Mulholland DL, Gotlieb AI. Cell biology of valvular interstitial cells. Can J Cardiol, 1996, 12(3): 231-236.
|
7. |
Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med, 2000, 343(9): 611-617.
|
8. |
Vamvakidou A, Karogiannis N, Ramzy I, et al. Exercise echocardiography in asymptomatic severe aortic stenosis. Int J Cardiovasc Imaging, 2015, 31(8): 1561-1562.
|
9. |
Gu X, Masters KS. Role of the Rho pathway in regulating valvular interstitial cell phenotype and nodule formation. Am J Physiol Heart Circ Physiol, 2011, 300(2): H448-H458.
|
10. |
Kumar A, Wiltz DC, Grande-Allen KJ. Gentamicin reduces calcific nodule formation by aortic valve interstitial cells. Cardiovasc Eng Technol, 2013, 4(1): 16-25.
|
11. |
Rajamannan NM, Sangiorgi G, Springett M, et al. Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Valve Dis, 2001, 10(3): 371-374.
|
12. |
Chu Y, Lund DD, Weiss RM, et al. Pioglitazone attenuates valvular calcification induced by hypercholesterolemia. Arterioscler Thromb Vasc Biol, 2013, 33(3): 523-532.
|
13. |
Jian B, Narula N, Li QY, et al. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg, 2003, 75(2): 457-465.
|
14. |
Pickar JH, Komm BS. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast. Post Reprod Health, 2015, 21(3): 112-121.
|
15. |
Meier C, Lamy O, Krieg MA, et al. The role of teriparatide in sequential and combination therapy of osteoporosis. Swiss Med Wkly, 2014, 144. w13952.
|
16. |
Lamas AZ, Caliman IF, Dalpiaz PL, et al. Comparative effects of estrogen, raloxifene and tamoxifen on endothelial dysfunction, inflammatory markers and oxidative stress in ovariectomized rats. Life Sci, 2015, 124: 101-109.
|
17. |
Sumino H, Ichikawa S, Kasama S, et al. Effects of raloxifene on brachial arterial endothelial function, carotid wall thickness, and arterial stiffness in osteoporotic postmenopausal women. Int Heart J, 2010, 51(1): 60-67.
|
18. |
Meyer MR, Prossnitz ER, Barton M. The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vascul Pharmacol, 2011, 55(1-3): 17-25.
|
19. |
Poirot M, Silvente-Poirot S, Weichselbaum RR. Cholesterol metabolism and resistance to tamoxifen. Curr Opin Pharmacol, 2012, 12(6): 683-689.
|
20. |
Shuvy M, Abedat S, Beeri R, et al. Raloxifene attenuates Gas6 and apoptosis in experimental aortic valve disease in renal failure. Am J Physiol Heart Circ Physiol, 2011, 300(5): H1829-H1840.
|